Takeda takeover of Shire looks to change the big pharma landscape
The Japanese company Takeda has reached a deal with Shire to buy the firm for £46 billion (US$62.2 billion), strengthening its existing IP portfolio
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.